RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
PTC Therapeutics Stock

PTC Therapeutics Liabilities 2024

PTC Therapeutics Liabilities

2.71 B USD

Ticker

PTCT

ISIN

US69366J2006

WKN

A1W0MW

In 2024, PTC Therapeutics's total liabilities amounted to 2.71 B USD, a 32.23% difference from the 2.05 B USD total liabilities in the previous year.

PTC Therapeutics Aktienanalyse

What does PTC Therapeutics do?

PTC Therapeutics Inc. is a biopharmaceutical company based in South Plainfield, New Jersey. The company was founded in 1998 and focuses on the research and development of drugs for the treatment of rare diseases. The company has two main divisions: product research and development, and science and innovation. Its product range includes several drugs for the treatment of rare diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and cystic fibrosis. One of its key products is Translarna, the first RNA-targeted drug approved for the treatment of Duchenne muscular dystrophy. Another product is Evrysdi, approved for the treatment of spinal muscular atrophy. PTC Therapeutics also has a pipeline of drugs being tested in clinical trials for various rare diseases. The company is committed to promoting innovation and has partnerships with academic institutions and other companies to explore and develop new therapies. Overall, PTC Therapeutics aims to improve the lives of patients with rare diseases through innovative treatments. PTC Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing PTC Therapeutics's Liabilities

PTC Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating PTC Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing PTC Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

PTC Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in PTC Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about PTC Therapeutics stock

What is the level of liabilities of PTC Therapeutics this year?

PTC Therapeutics has a debt balance of 2.71 B USD this year.

What were the liabilities of PTC Therapeutics compared to the previous year?

The liabilities of PTC Therapeutics have increased by 32.23% increased compared to the previous year.

What are the consequences of high debt for investors of PTC Therapeutics?

High liabilities can pose a risk for investors of PTC Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in PTC Therapeutics?

Low liabilities mean that PTC Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of PTC Therapeutics affect the company?

An increase in liabilities of PTC Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of PTC Therapeutics affect the company?

A decrease in the liabilities of PTC Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of PTC Therapeutics?

Some factors that can influence the liabilities of PTC Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of PTC Therapeutics so important for investors?

The liabilities of PTC Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can PTC Therapeutics take to modify the liabilities?

To change its liabilities, PTC Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does PTC Therapeutics pay?

Over the past 12 months, PTC Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PTC Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of PTC Therapeutics?

The current dividend yield of PTC Therapeutics is .

When does PTC Therapeutics pay dividends?

PTC Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PTC Therapeutics?

PTC Therapeutics paid dividends every year for the past 0 years.

What is the dividend of PTC Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PTC Therapeutics located?

PTC Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von PTC Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PTC Therapeutics from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did PTC Therapeutics pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of PTC Therapeutics in the year 2023?

In the year 2023, PTC Therapeutics distributed 0 USD as dividends.

In which currency does PTC Therapeutics pay out the dividend?

The dividends of PTC Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PTC Therapeutics

Our stock analysis for PTC Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PTC Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.